Dr. Fulai Jin's lab focuses on understanding the three-dimensional structure of the genome and its role in gene regulation and disease, particularly how genetic variations influence DNA looping in cells. Using advanced techniques like Hi-C and deep learning, the lab investigates the intricate relationships between chromatin organization and gene expression, leveraging mouse models to draw insights relevant to human biology and diseases such as diabetes.

Dr. Berkley E. Gryder's lab at Case Western Reserve University studies advanced prostate cancer, focusing on understanding how the androgen receptor (AR) can be targeted to suppress cancer growth. They are developing innovative small molecule therapies that can switch the function of the AR from promoting tumor growth to inhibiting it. By exploring the molecular and epigenetic mechanisms involved, the lab aims to improve treatment strategies for patients with resistant forms of prostate cancer.

Dr. Yan Li's lab focuses on understanding pancreatic beta-cell biology and its implications for diabetes. They study how variations in genetic factors, particularly the gene HNF1A, affect the development and function of these cells. By using advanced techniques like single-cell genomic analyses, they aim to develop better strategies for generating functional beta-cells from stem cells, which could be crucial for diabetes therapies.

Dr. Zhenghe Wang's lab focuses on understanding the role of a specific gene known as PTPRT in the development and spread of colorectal cancer. They investigate how mutations in this gene disrupt normal cellular processes, resulting in cancer cell growth and metastasis. The lab aims to discover new therapeutic targets by exploring the mechanisms behind protein modifications that influence cancer progression.

Dr. Maria Hatzoglou's lab focuses on how cells adapt to stress, specifically dehydration, by regulating protein synthesis. This research is important for understanding and treating diseases like diabetes and dry eye syndrome, which are linked to problems with cellular responses to stress. By studying how cells adjust their internal processes during dehydration, the lab aims to uncover new therapeutic strategies to improve cell survival in various health conditions.

Dr. Ashleigh Schaffer's lab at Case Western Reserve University focuses on understanding the genetic causes of neurodegenerative diseases, especially those that affect children. They study the role of RNA-binding proteins in neuron health and how mutations in these proteins can lead to severe brain disorders. By using innovative models like human stem cells and animal studies, the lab aims to identify new therapeutic approaches for treating these devastating diseases.

Dr. Drew James Adams' lab focuses on developing targeted therapies for autoimmune diseases by understanding how T cells become pathologically activated. The research is based on selective inhibitors that can modulate T cell function without broadly suppressing the immune system, potentially leading to treatments with fewer side effects. The lab investigates the molecular mechanisms of these inhibitors and aims to optimize their efficacy in managing diseases like rheumatoid arthritis and graft-versus-host disease.